Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm
- PMID: 29296433
- PMCID: PMC5658880
Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm
Abstract
Purpose: We investigate clinical, pathologic, and treatment paradigm-related factors affecting local control of brain metastases after stereotactic radiosurgery (SRS) with or without whole brain radiotherapy (WBRT).
Methods and materials: Patients with brain metastases treated with SRS alone, before or after WBRT were considered to determine predictors of local failure (LF), time to failure and survival.
Results: Among 137 patients, 411 brain metastases were analyzed. 23% of patients received SRS alone, 51% received WBRT prior to SRS, and 26% received SRS followed by WBRT. LF occurred in 125 metastases: 63% after SRS alone, 20% after WBRT then SRS, and 22% after SRS then WBRT. Median time to local failure was significantly less after SRS alone compared to WBRT then SRS (12.1 v. 22.7 months, p=0.003). Tumor volume was significantly associated with LF (HR:5.2, p<0.001, 95% CI:3.4-7.8).
Conclusions: WBRT+SRS results in reduced LF. Local control was not significantly different after SRS as salvage therapy versus upfront SRS.
Keywords: brain metastasis; local failure; salvage therapy; stereotactic radiosurgery; treatment paradigm; whole brain radiotherapy.
Conflict of interest statement
Authors’ disclosure of potential conflicts of interest The authors reported no conflict of interest.
Figures
References
-
- Andrews D.W., et al. , Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet, 2004. 363(9422): p. 1665-72. - PubMed
-
- Aoyama H., et al. , Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA, 2006. 295(21): p. 2483-91. - PubMed
-
- Chang E.L., et al. , Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol, 2009. 10(11): p. 1037-44. - PubMed
-
- Soffietti R., et al. , A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol, 2013. 31(1): p. 65-72. - PubMed